Literature DB >> 25017420

Treatment with essential oil of Achyrocline satureioides in rats infected with Trypanosoma evansi: relationship between protective effect and tissue damage.

Matheus D Baldissera1, Camila B Oliveira2, Virginia C Rech3, João F Peres Rezer2, Michele R Sagrillo4, Marta P Alves3, Ana P T da Silva3, Daniela B R Leal2, Aline A Boligon5, Margareth L Athayde5, Aleksandro S Da Silva6, Ricardo E Mendes7, Silvia G Monteiro8.   

Abstract

The aim of this study was to evaluate the effects of treatment with free and nanoencapsulated essential oil of Achyrocline satureioides on trypanosomosis and its oxidative/antioxidants variables in liver and kidney of rats infected experimentally with Trypanosoma evansi. For that, 48 rats were divided into six groups (A-F), eight animals each group. Groups A, C and D were composed of uninfected animals, while animals in groups B, E and F were inoculated intraperitoneally with T. evansi. Groups A and B were used as controls, negative and positive, respectively. Groups C and E receive oil (orally), as well as the animals in groups D and F were treated with nanoencapsulated essential oil. The treatment was not able to eliminate the parasites, but it remained the levels of parasitemia low. The carbonyl levels in liver and kidney did not differ between groups. Infected animals (group B) showed an increase in the TBARS levels and a decrease in the CAT activity and NPSH levels in liver and kidney, compared with the same parameters in the control (group A). Treatment with A. satureioides (groups C and D) did not influence the TBARS levels and CAT activity in the liver, but it increased the CAT activity in kidneys of the animals of group C. NPSH levels decreased in liver in the groups treated with nanoencapsulated essential oil (groups D and F). An interesting result observed was that the animals infected and then treated with essential oil of A. satureioides (groups E and F) did not differ from animals of group A for TBARS, CAT and NPSH, unlike what happened with the animals of group B. Therefore, the treatment with essential oil did not eliminate the parasites from the bloodstream, but it reduced the number of trypanosomes, mainly by its nanoencapsulated form. The same occurred with the lipid peroxidation in the liver. However, the treatments reduced the oxidative damage, and it led to the activation of the antioxidant enzymes. We believe that the association of this natural product with a trypanocidal drug may enhance its curative effect.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  CAT; NPSH; TBARS; Trypanosomosis

Mesh:

Substances:

Year:  2014        PMID: 25017420     DOI: 10.1016/j.prp.2014.06.008

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  4 in total

1.  Untargeted LC-MS metabolomic studies of Asteraceae species to discover inhibitors of Leishmania major dihydroorotate dehydrogenase.

Authors:  Lucas A Chibli; Annylory L Rosa; Maria Cristina Nonato; Fernando B Da Costa
Journal:  Metabolomics       Date:  2019-04-04       Impact factor: 4.290

2.  Nerolidol-loaded nanospheres prevent behavioral impairment via ameliorating Na+, K+-ATPase and AChE activities as well as reducing oxidative stress in the brain of Trypanosoma evansi-infected mice.

Authors:  Matheus D Baldissera; Carine F Souza; Thirssa H Grando; Karen L S Moreira; Andressa S Schafer; Luciana F Cossetin; Ana P T da Silva; Marcelo L da Veiga; Maria Izabel U M da Rocha; Lenita M Stefani; Aleksandro S da Silva; Silvia G Monteiro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-11-02       Impact factor: 3.000

3.  Hypolipidemic effect of β-caryophyllene to treat hyperlipidemic rats.

Authors:  Matheus D Baldissera; Carine F Souza; Thirssa H Grando; Pedro H Doleski; Aline A Boligon; Lenita M Stefani; Silvia G Monteiro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-02       Impact factor: 3.000

4.  Oxidative Stress in the Heart of Rats Infected with Trypanosoma evansi.

Authors:  Matheus D Baldissera; Carine de F Souza; Cláudia M Bertoncheli; Karine L da Silveira; Thirssa H Grando; Bianca C Z Porto; Daniela B R Leal; Aleksandro S Da Silva; Ricardo E Mendes; Lenita M Stefani; Silvia G Monteiro
Journal:  Korean J Parasitol       Date:  2016-06-30       Impact factor: 1.341

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.